Editor’s note: Drugs are listed in alphabetical order.
1. Sulfacetamide sodium and prednisolone sodium phosphate ophthalmic solution. Drugmaker Bausch Health is the sole supplier of this eye drop that treats eye infections and inflammation. The company did not provide a reason for the shortage. The product is on backorder and Bausch cannot estimate a restock date.
2. Topotecan capsules. Sandoz’s 0.25 milligram and 1 milligram dose capsules of this small cell lung cancer treatment are in short supply. The drugmaker did not provide a reason for the shortage and has the capsules on backorder with an estimated restock date in November.
3. Trimethobenzamide injection. This injection used to treat nausea and vomiting is in short supply. Par Pharmaceuticals, the drug’s manufacturer, said the reason for the shortage is increased demand. The company has 100mg/mL vials on intermittent backorder and will release supplies as they become available.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.